NCT05155605: An ongoing trial by GRAIL, Inc.
This trial is ongoing. It must report results 4 months, 2 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05155605 |
|---|---|
| Title | The PATHFINDER 2 Study: Evaluating the Safety and Performance of the GRAIL Multi-Cancer Early Detection Test in an Eligible Screening Population |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 8, 2021 |
| Completion date | Feb. 11, 2026 |
| Required reporting date | Feb. 11, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Sept. 21, 2026 |
| Days late | None |